Touchlight boosts DNA manufacturing capacity with latest expansion
Pharmaceutical Technology
MAY 26, 2023
Tripling its production capacity, Touchlight can now manufacture 8kg plasmid DNA, a key component for mRNA gene therapies and vaccines. As per the company, dbDNA is suitable for rapid, scalable manufacture of GMP DNA and can incorporate gene sequences of sizes ranging from 500bp to 20kb, which are typically unstable as pDNA.
130 
Let's personalize your content